116 related articles for article (PubMed ID: 2585201)
1. [Clinical evaluation of local administration of RIL-2 in head and neck cancer].
Saito T; Kakiuti H; Kuki K; Yokota M; Jinnin T; Kimura T; Fujiwara K; Yoda J; Kunimoto M; Arai H
Nihon Jibiinkoka Gakkai Kaiho; 1989 Aug; 92(8):1265-70. PubMed ID: 2585201
[TBL] [Abstract][Full Text] [Related]
2. Local administration trials of interleukin-2 for head and neck cancer.
Saito T; Yoda J; Tabata T
Auris Nasus Larynx; 1991; 18(2):169-78. PubMed ID: 1741710
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of local immunochemotherapy of head and neck cancer].
Saito T
Nihon Jibiinkoka Gakkai Kaiho; 1991 Dec; 94(12):1898-912. PubMed ID: 1779275
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistology of tumor tissue in local administration of recombinant interleukin-2 in head and neck cancer].
Saito T; Kawaguti T; Yoda J; Kimura T; Tabata T
Nihon Jibiinkoka Gakkai Kaiho; 1989 Aug; 92(8):1271-6. PubMed ID: 2685216
[TBL] [Abstract][Full Text] [Related]
5. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
Ohguri T; Imada H; Nomoto S; Yahara K; Hisaoka M; Hashimoto H; Tokura Y; Nakamura K; Shioyama Y; Honda H; Terashima H; Moroi Y; Furue M; Korogi Y
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1446-53. PubMed ID: 15817349
[TBL] [Abstract][Full Text] [Related]
6. Local adoptive immunotherapy of advanced head and neck tumors with LAK cells and interleukin-2.
Squadrelli-Saraceno M; Rivoltini L; Cantù G; Ravagnani F; Parmiani G; Molinari R
Tumori; 1990 Dec; 76(6):566-71. PubMed ID: 2284694
[TBL] [Abstract][Full Text] [Related]
7. [A dramatic effect of continuous intra-arterial injected recombinant interleukin-2 immunotherapy on malignant hemangioendothelioma].
Takano M; Suzuki Y; Asai T; Masuzawa M; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):719-25. PubMed ID: 1942580
[TBL] [Abstract][Full Text] [Related]
8. A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.
Weiss GR; Margolin KA; Aronson FR; Sznol M; Atkins MB; Dutcher JP; Gaynor ER; Boldt DH; Doroshow JH; Bar MH
J Clin Oncol; 1992 Feb; 10(2):275-81. PubMed ID: 1732429
[TBL] [Abstract][Full Text] [Related]
9. [A phase 2 study of recombinant interleukin 2 (S-6820) for head and neck cancer].
Sawaki S
Gan No Rinsho; 1990 Feb; 36(2):111-20. PubMed ID: 2308207
[TBL] [Abstract][Full Text] [Related]
10. [The effect of IL-2 injection around the metastatic cervical lymphnode].
Ogasawara H; Takeda N; Takeda N; Kumoi T
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1119-22. PubMed ID: 2398297
[TBL] [Abstract][Full Text] [Related]
11. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
[TBL] [Abstract][Full Text] [Related]
12. Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.
Sacchi M; Snyderman CH; Heo DS; Johnson JT; d'Amico F; Herberman RB; Whiteside TL
Cancer Res; 1990 May; 50(10):3113-8. PubMed ID: 2334906
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy of recombinant interleukin 2 in local treatment of superficial bladder tumors].
Fujioka T; Shiraishi M; Tanji S; Sato S; Koike H; Aoki H; Suzuki K; Kumagai K; Banya Y; Kubo T
Hinyokika Kiyo; 1988 Dec; 34(12):2115-9. PubMed ID: 3266444
[TBL] [Abstract][Full Text] [Related]
14. Multiple cycles of constant infusion recombinant interleukin-2 in adoptive cellular therapy of metastatic renal carcinoma.
West WH; Tauer KW; Yannelli JR; Marshall GD; Orr D; Lewis M; Birch R; Oldham RK
Mol Biother; 1989; 1(5):268-74. PubMed ID: 2619946
[TBL] [Abstract][Full Text] [Related]
15. [Continuous arterial infusion therapy of recombinant interleukin-2 and cyclophosphamide in hepatoma and liver metastasis].
Hayakawa K; Fukushima T; Seito D; Asakura Y; Yamanaka Y; Morita T; Sasaki M; Konn M; Ono K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2842-4. PubMed ID: 2551226
[TBL] [Abstract][Full Text] [Related]
16. Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.
Velotti F; Tubaro A; Stoppacciaro A; Pettinato A; Morrone S; Bossola P; Napolitano T; Miano L; Ruco L; Piccoli M
Ann Ist Super Sanita; 1990; 26(3-4):411-21. PubMed ID: 2091503
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma.
Watts RG; Merchant RE
Neurosurgery; 1992 Jul; 31(1):89-98; discussion 98-9. PubMed ID: 1641114
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferon.
Besana C; Borri A; Bucci E; Citterio G; Di Lucca G; Fortis C; Matteucci P; Tognella S; Tresoldi M; Baiocchi C
Eur J Cancer; 1994; 30A(9):1292-8. PubMed ID: 7999416
[TBL] [Abstract][Full Text] [Related]
19. [Local immunotherapy of breast cancer: a case of advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2].
Fujimori M; Sugenoya A; Kobayashi S; Masuda H; Komatsu M; Takahashi S; Shimizu T; Tsuchiya S; Iida F
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2760-3. PubMed ID: 2551219
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alpha.
Wanebo H; Blackinton D; Weigel T; Turk P; Mehta S
Am J Surg; 1991 Oct; 162(4):384-7. PubMed ID: 1951894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
